stockrowQuest Diagnostics Incorporated (DGX) vs Guardant Health, Inc. (GH)
- Quest Diagnostics Incorporated DGX 254.25 −0.56%
- Guardant Health, Inc. GH 154.16 −8.55%
Quest Diagnostics Incorporated and Guardant Health, Inc. are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $28.0B against $20.6B — 1.4× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Quest Diagnostics Incorporated trades at 25.0×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 9.13%. Quest Diagnostics Incorporated has the higher net margin (9.50% vs −37.9%) and the higher return on invested capital (8.48% vs −25.7%). Across the 18 metrics below, Quest Diagnostics Incorporated leads on 10 and Guardant Health, Inc. on 8.
Valuation
Profitability
| Metric | DGX | GH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.11% | 65.19% | 48.32% |
| Operating margin | 14.55% | (39.41%) | (5.68%) |
| Net margin | 9.50% | (37.93%) | (4.10%) |
| Free cash flow margin | 11.61% | (18.15%) | 0.00% |
| Return on equity | 14.76% | 153.90% | 0.00% |
| Return on assets | 6.73% | (30.68%) | (6.05%) |
| Return on invested capital | 8.48% | (25.68%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack